MedTrace Logo

Laser Intervention in Early Age-Related Macular Degeneration Study

NCT01790802 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 292

Last updated 2025-04-15

No results posted yet for this study

Summary

The purpose of this study is to determine whether 2RT nanosecond laser therapy slows the progression to advanced age-related macular degeneration.

Conditions

  • Age-related Macular Degeneration

Interventions

DEVICE

2RT nanosecond laser

active laser therapy

Sponsors & Collaborators

  • Center for Eye Research Australia

    lead OTHER

Principal Investigators

  • Robyn H Guymer, PhD, FRANZCO · Deputy Director CERA

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2018-05-01
Completion
2018-05-01

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01790802 on ClinicalTrials.gov